Generic
Mirogabalin Besylate

Description
Miraba 2.5, manufactured by ACME Laboratories Ltd., is a medication used to manage neuropathic pain conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, and peripheral neuropathic pain.

Benefits
Miraba 2.5 effectively reduces neuropathic pain by decreasing calcium influx and neurotransmitter release in neurons, relieving chronic pain associated with diabetes, shingles, and other conditions.

Ingredients
The active ingredient in Miraba 2.5 is Mirogabalin Besylate, formulated as 2.5 mg tablets.

Uses and Doses
For adults, the initial dose is 5 mg twice daily, gradually increasing by 5 mg weekly to 15 mg twice daily based on symptoms. For patients with renal impairment, dosage adjustments are required. Miraba is not recommended for children or adolescents, and its safety in these age groups is not established.

Side Effects
Common side effects include dizziness, somnolence, edema, and weight gain. Rarely, patients may experience jaundice, loss of consciousness, or nausea. If severe symptoms occur, consult a doctor immediately.

How to Use
Take Miraba 2.5 as directed by your physician, usually twice daily. It can be taken with or without food. Avoid consuming alcohol during treatment.

Pregnancy & Lactation
Miraba should only be used for pregnant women by pregnant women if the benefits outweigh the risks. Animal studies have shown that Mirogabalin is present in the placenta and breast milk, so breastfeeding should be considered carefully.

Precautions and Warnings
This medicine may cause drowsiness or dizziness. Avoid operating machinery or driving while taking Miraba. Exercise caution in elderly patients, as successful falls or fractures can occur. Consult a doctor if you experience vision changes, allergic reactions, or significant weight gain.

Safety Information
Store Miraba 2.5 below 30°C in a dry place, away from light and moisture. Keep it out of reach of children.

Indications
Miraba 2.5 is indicated for treating neuropathic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, and peripheral neuropathic pain.

Pharmacology
Mirogabalin selectively binds to α2δ subunits of voltage-gated calcium channels, reducing calcium influx and neurotransmitter release and decreasing neuron hyperexcitability. Low plasma protein binding and rapid renal excretion enhance its efficacy and safety.

Therapeutic Class
Adjunct and primary anti-epileptic drugs.

Storage Conditions
Store in a cool, dry place below 30°C, protected from light and moisture.

3 FAQ

1. Can Miraba 2.5 be taken with food?
   Yes, food does not affect its absorption significantly.
2. Is Miraba 2.5 safe for children?
   Its safety in children and adolescents has not been established.
3. Can I drive while taking Miraba?
   Avoid driving or operating machinery, as it may cause dizziness or drowsiness.

Disclaimer
This information is for educational purposes only and should not replace medical advice. Always consult your healthcare provider before starting any medication.

Keywords: Miraba 2.5, Mirogabalin Besylate, neuropathic pain, diabetic peripheral neuropathy, postherpetic neuralgia, peripheral neuropathy, ACME Laboratories, pain relief, nerve pain, neuralgia treatment, diabetic pain management, anti-epileptic drug, alpha-2-delta ligands, neuropathy treatment, somnolence, dizziness, blurred vision, edema, renal impairment dose adjustment, neuropathy medication, Miraba dosage.